9.1.0 Anaemias and some other blood disorders
Caplacizumab
Caplacizumab 10mg powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Thrombocytopenic purpura |
Fibrinogen
Fibryga 1g powder and solvent for solution for infusion bottles
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Hypofibrinogenaemia |
Fibrinogen + Thrombin
Fibrinogen 5.5mg/square cm / Thrombin 2units/square cm implant 2.5cm x 3cm
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Haemostasis |
Fibrinogen 5.5mg/square cm / Thrombin 2units/square cm implant 4.8cm x 4.8cm
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Haemostasis |
Fibrinogen 5.5mg/square cm / Thrombin 2units/square cm implant 4.8cm x 9.5cm
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Haemostasis |
Hydroxycarbamide
Hydroxycarbamide 500mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Sickle cell anaemia |
Hydroxycarbamide 500mg/5ml oral solution sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Sickle cell anaemia |
Prothrombin complex
Beriplex P/N 1,000 powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Haemostasis |
Beriplex P/N 250 powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Haemostasis |
Beriplex P/N 500 powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Haemostasis |
Rituximab
Rituximab 100mg/10ml solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Nutrition and blood | Acquired haemophilia |
| Nutrition and blood | Thrombocytopenic purpura |